Clinical trial

Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy

NCT07036796

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-07-04

PhasePHASE2

Study timeline

Study start (actual)2025-07-04Date precision: day

Registry last updated2026-07-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Peripheral Neuropathyunresolved

Diabetic Neuropathyunresolved

Diabetic Peripheral Neuropathy in Type 2 Diabetic Patientsunresolved

Interventions

MelatoninDRUG · verified · RxNorm: melatonin

Sponsors & collaborators

Ain Shams Universitylead sponsor

Mapped research locations

CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07036796 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.